See more : BB Biotech AG (BBZA.DE) Income Statement Analysis – Financial Results
Complete financial analysis of 4Cs HD Co., Ltd. (3726.T) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of 4Cs HD Co., Ltd., a leading company in the Specialty Retail industry within the Consumer Cyclical sector.
- Hammerhead Energy Inc. (HHRS) Income Statement Analysis – Financial Results
- NeurAxis, Inc. (NRXS) Income Statement Analysis – Financial Results
- Credo Brands Marketing L (MUFTI.NS) Income Statement Analysis – Financial Results
- Alkali Metals Limited (ALKALI.NS) Income Statement Analysis – Financial Results
- Vapotherm, Inc. (VAPO) Income Statement Analysis – Financial Results
4Cs HD Co., Ltd. (3726.T)
About 4Cs HD Co., Ltd.
4Cs HD Co., Ltd. engages in the mail order, retail, wholesale, and hygiene consulting businesses in Japan and internationally. The company's wholesale business sells cosmetics, health food, and aromatherapy related products through its stores, as well as through drug and variety stores. Its retail business provides aromatherapy products and essential oils under the Aroma Bloom brand name. The company's mail order business offers cosmetics, health food, and aromatherapy related products through its call center and website. Its hygiene consulting business sells and inspects BACTESTER; and provides space sterilization devices and hazard analysis critical control point certification consultation services. The company also offers femcare products under the CharmMakeBody, Omahit, and RhinoWolf brands. 4Cs HD Co., Ltd. was formerly known as 4Cs Holdings Co., Ltd. The company was incorporated in 2003 and is headquartered in Fukuoka City, Japan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 2.14B | 2.32B | 2.47B | 1.96B | 1.98B |
| Cost of Revenue | 706.00M | 745.38M | 693.68M | 564.52M | 510.31M |
| Gross Profit | 1.43B | 1.58B | 1.78B | 1.39B | 1.47B |
| Gross Profit Ratio | 66.96% | 67.93% | 71.94% | 71.18% | 74.22% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 1.46B | 1.53B | 1.42B | 1.13B | 1.20B |
| Selling & Marketing | 130.00M | 138.00M | 471.00M | 632.00M | 448.00M |
| SG&A | 1.59B | 1.67B | 1.89B | 1.76B | 1.65B |
| Other Expenses | 52.00M | 10.19M | 6.43M | 4.48M | -52.59M |
| Operating Expenses | 1.65B | 1.70B | 1.93B | 1.79B | 1.70B |
| Cost & Expenses | 2.35B | 2.44B | 2.62B | 2.36B | 2.21B |
| Interest Income | 6.00K | 7.00K | 24.00K | 33.00K | 13.00M |
| Interest Expense | 5.92M | 5.78M | 7.82M | 11.10M | 13.58M |
| Depreciation & Amortization | 48.00M | 44.74M | 62.09M | 61.60M | 101.35M |
| EBITDA | -206.57M | -96.21M | -122.10M | -399.48M | -205.94M |
| EBITDA Ratio | -9.67% | -2.86% | -3.26% | -16.94% | -6.58% |
| Operating Income | -214.21M | -119.08M | -148.36M | -397.83M | -231.57M |
| Operating Income Ratio | -10.02% | -5.12% | -6.00% | -20.31% | -11.70% |
| Total Other Income/Expenses | -46.28M | -27.65M | -43.64M | -74.35M | -89.29M |
| Income Before Tax | -260.50M | -146.73M | -192.00M | -472.18M | -320.86M |
| Income Before Tax Ratio | -12.19% | -6.31% | -7.77% | -24.11% | -16.21% |
| Income Tax Expense | 12.13M | 9.80M | -13.81M | -7.25M | 47.06M |
| Net Income | -272.62M | -156.53M | -178.20M | -464.83M | -367.92M |
| Net Income Ratio | -12.76% | -6.73% | -7.21% | -23.73% | -18.58% |
| EPS | -35.29 | -21.77 | -24.94 | -68.02 | -54.09 |
| EPS Diluted | -35.29 | -21.77 | -24.94 | -68.02 | -54.09 |
| Weighted Avg Shares Out | 7.73M | 7.19M | 7.15M | 6.83M | 6.80M |
| Weighted Avg Shares Out (Dil) | 7.73M | 7.19M | 7.15M | 6.83M | 6.80M |
Source: https://incomestatements.info
Category: Stock Reports